Department of Emergency Medicine, the Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Eur Rev Med Pharmacol Sci. 2017 Nov;21(21):5008-5016.
Glycogen synthase kinase-3β (GSK-3β) can phosphorylate and degrade β-catenin, and negatively regulates Wnt/β-catenin signal pathway. MiR-224 up-regulation is associated with colorectal cancer (CRC). Bioinformatics analysis showed complementary binding sites between miR-224 and GSK-3β. This study investigated if miR-224 plays a role in mediating GSK-3β expression, Wnt/β-catenin pathway activity, CRC cell proliferation, apoptosis as well as drug sensitivity of Adriamycin (ADM).
Dual luciferase gene reporter assay demonstrated the regulatory relationship between miR-224 and GSK-3β. Expression of miR-224, GSK-3β, β-catenin, and Survivin was measured in normal colon epithelium NCM460, CRC cell line SW480, and drug-resistant SW480/ADM cell line. Flow cytometry measured apoptosis under ADM with an IC50 concentration of SW480 cells, followed by CCK-8 analysis of cell proliferation. SW480/ADM cells were treated with miR-224 inhibitor and/or pSicoR-GSK-3β, followed by analysis of the expressions of GSK-3β, β-catenin and Survivin, cell apoptosis, and cell proliferation by EdU staining.
MiR-224 targeted and inhibited GSK-3β expression. In SW480/ADM cells, GSK-3β expression and cell apoptosis rate were lower than those in SW480 cells, whilst miR-224, β-catenin, and Survivin expression or proliferation were higher than those in SW480 cells. Transfection of miR-224 inhibitor and/or pSicoR-GSK-3β significantly increased GSK-3β expression in SW480/ADM cells, and decreased β-catenin and Survivin expression, leading to reduced proliferation potency, enhanced cell apoptosis and suppressed ADM resistance.
MiR-224 up-regulation is associated with ADM resistance of CRC cells. Suppression of miR-224 expression up-regulated GSK-3β expression, inhibited Wnt/β-catenin signal pathway activity and Survivin expression, as well as reduced ADM resistance of CRC SW480 cells.
糖原合成酶激酶-3β(GSK-3β)可以磷酸化并降解β-连环蛋白,从而负调控 Wnt/β-连环蛋白信号通路。miR-224 的上调与结直肠癌(CRC)有关。生物信息学分析显示 miR-224 与 GSK-3β 之间存在互补结合位点。本研究探讨了 miR-224 是否在介导 GSK-3β 表达、Wnt/β-连环蛋白通路活性、CRC 细胞增殖、凋亡以及阿霉素(ADM)敏感性中发挥作用。
双荧光素酶基因报告实验证实了 miR-224 与 GSK-3β 之间的调控关系。检测正常结肠上皮细胞系 NCM460、CRC 细胞系 SW480 和耐药 SW480/ADM 细胞系中 miR-224、GSK-3β、β-连环蛋白和 Survivin 的表达。用 ADM 的 IC50 浓度处理 SW480 细胞后,通过流式细胞术检测细胞凋亡,然后用 CCK-8 分析细胞增殖。用 miR-224 抑制剂和/或 pSicoR-GSK-3β 处理 SW480/ADM 细胞,然后通过 EdU 染色分析 GSK-3β、β-连环蛋白和 Survivin 的表达、细胞凋亡和细胞增殖。
miR-224 靶向并抑制 GSK-3β 的表达。在 SW480/ADM 细胞中,GSK-3β 的表达和细胞凋亡率低于 SW480 细胞,而 miR-224、β-连环蛋白和 Survivin 的表达或增殖高于 SW480 细胞。转染 miR-224 抑制剂和/或 pSicoR-GSK-3β 可显著增加 SW480/ADM 细胞中的 GSK-3β 表达,降低β-连环蛋白和 Survivin 的表达,从而降低增殖能力,增强细胞凋亡,并抑制 ADM 耐药性。
miR-224 的上调与 CRC 细胞对 ADM 的耐药性有关。抑制 miR-224 的表达可上调 GSK-3β 的表达,抑制 Wnt/β-连环蛋白信号通路的活性和 Survivin 的表达,从而降低 CRC SW480 细胞对 ADM 的耐药性。